🟢 Iovance Biotherapeutics is trading 4.52% up today with no clear new catalyst

Iovance Biotherapeutics is trading at $6.82, up +4.52%, with no clear company-specific catalyst identified for August 14, 2026.

• No clear company-specific announcement dated August 14, 2026, was identified in available coverage.
• Recent reports discuss the August 6, 2026, quarterly revenue beat and FDA Fast Track designation, but neither catalyst is new today.
• Broader markets are modestly lower and do not clearly explain the gain.